Zobrazeno 1 - 10
of 30
pro vyhledávání: '"V. Ektare"'
Publikováno v:
Applied Health Economics and Health Policy
Background Bevacizumab remains the most widely used and most thoroughly characterized angiogenesis inhibitor for a range of advanced cancers. Bevacizumab-bvzr (Zirabev®), a biosimilar of bevacizumab, was recently approved by the US Food and Drug Adm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aca454fe29aa0c93dee0daffd167e05d
https://doi.org/10.1007/s40258-021-00637-5
https://doi.org/10.1007/s40258-021-00637-5
Publikováno v:
Value in Health. 25:S379
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e15c25c1ab92973f510614cec29f26bc
https://doi.org/10.1016/j.jval.2022.04.479
https://doi.org/10.1016/j.jval.2022.04.479
Publikováno v:
Value in Health. 23:S14-S15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60fb415baf0f42ad5812d92d548d42f8
https://doi.org/10.1016/j.jval.2020.04.075
https://doi.org/10.1016/j.jval.2020.04.075
Publikováno v:
Value in Health. 23:S16-S17
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2132e75c21ac70eddda973ff8217e670
https://doi.org/10.1016/j.jval.2020.04.084
https://doi.org/10.1016/j.jval.2020.04.084
Publikováno v:
Value in Health. 24:S70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c00085bdd568fef0a5fae78580ba1ff6
https://doi.org/10.1016/j.jval.2021.04.361
https://doi.org/10.1016/j.jval.2021.04.361
Publikováno v:
Value in Health. 23:S15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48dd16bc1a34cbd7115b34798379f9e4
https://doi.org/10.1016/j.jval.2020.04.076
https://doi.org/10.1016/j.jval.2020.04.076
Publikováno v:
Journal of Medical Economics. 18:1092-1101
To estimate, from a US payer perspective, the cost offsets of treating gram positive acute bacterial skin and skin-structure infections (ABSSSI) with varied hospital length of stay (LOS) followed by outpatient care, as well as the cost implications o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a457ea9d44f81375b9a914ecbaa492d
https://doi.org/10.3111/13696998.2015.1078339
https://doi.org/10.3111/13696998.2015.1078339
Autor:
Floris A. de Jong, Fortunato Ciardiello, Yoojung Yang, Alfredo Carrato, Jean-Frédéric Blanc, Richard A Hubner, V. Ektare, Arndt Vogel, Sharlene Gill, Dipen Patel
Publikováno v:
Cancer treatment reviews. 50
A systematic review and critical evaluation of randomized trial evidence for oxaliplatin- or irinotecan-containing regimens in patients with advanced pancreatic cancer previously treated with gemcitabine has not yet been published. We conducted a com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db3f1d7c0f9c13e3aeae9ca799cf680a
https://pubmed.ncbi.nlm.nih.gov/27676174
https://pubmed.ncbi.nlm.nih.gov/27676174
Autor:
V. Ektare, A. Marinho, V. Martins, L. Figueira, C. Silva, R. Proença, M. Botteman, A.R. Crespo, S.A. Farinha, F. Godinho, V. Nogueira
Publikováno v:
Value in Health. 21:S452
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cbf964970c994dd3ef256561bf90c77
https://doi.org/10.1016/j.jval.2018.09.2671
https://doi.org/10.1016/j.jval.2018.09.2671
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.